Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia in adults [see Clinical Studies (14.1)]. Schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants [see Clinical Studies (14.2)].
- generic_name
- paliperidone palmitate
- product_names
- paliperidone palmitate
- ndc
- 50458-560, 50458-561, 50458-562, 50458-563, 50458-564, 50458-560-01, 50458-561-01, 50458-562-01, 50458-563-01, 50458-563-03, 50458-564-01, 50458-564-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en